Angiogenesis and Neoplastic Transformation

  • Pietro M. Gullino
Part of the NATO ASI Series book series (NSSA, volume 227)


The major symptom of the neoplastic diseases is the unrestrained growth of cell populations with formation in most cases of solid tumors. Passage of cells into circulation and metastases formation completes the lethal outcome of the disease. When an agglomerate of cells is being formed in vivo, the increment in volume is conditioned by the supply system that sustains the metabolic needs. Thus, tumor formation requires not only the presence of a neoplastic cell population but also the participation of the host tissues supplying the vascular network. If this does not occur, the formation or growth of a solid tumor does not occur either. The validity of this conclusion was demonstrated several years ago1.


Mammary Gland Neoplastic Transformation Neoplastic Tissue Angiogenic Response Preneoplastic Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S. Brem, The role of vascular proliferation in the growth of brain tumors, Clinical Neurosurgery, 23:440–453 (1976).PubMedGoogle Scholar
  2. 2.
    S. Brem, H. Brem, J. Folkman, D. Finkelstein and A. Patz, Prolonged tumor dormancy by prevention of neovascularization in the vitreous, Cancer Res., 36:2807–2812 (1976).PubMedGoogle Scholar
  3. 3.
    P. M. Gullino, S. H. Clark and F. H. Grantham, The interstitial fluid of solid tumors, Cancer Res., 24:780–798 (1964).PubMedGoogle Scholar
  4. 4.
    P. M. Gullino, F. H. Grantham and S. H. Smith, The interstitial water space of tumors, Cancer Res., 25:727–731 (1965).PubMedGoogle Scholar
  5. 5.
    M. Ziche, J. Jones and P. M. Gullino, Role of prostaglandin El and copper in angiogenesis, J Natl Cancer Inst., 69:475–482 (1982).PubMedGoogle Scholar
  6. 6.
    D. Tuan, S. Smith, J. Folkman and I. Merler, Isolation of the non histone proteins of rat Walker carcinoma 256 their association with tumor angiogenesis, Biochemistry, 12:3159–3165 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    B. R. McAuslan and H. Hoffman, Endothelium stimulating factor from Walker carcinoma cells. Relation to tumor angiogenic factor, Exp. Cell Res. 119:181–190 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    J. B. Weiss, R. A. Brown, S. Kumar and P. Phillips, An angiogenic factor isolated from tumors. A potent low molecular weight compound, Br. J. Cancer, 40:493–496 (1979).PubMedCrossRefGoogle Scholar
  9. 9.
    P. M. Gullino, Angiogenesis factors, in “Handbook of Exp. Pharmacology”, R. Baserga, ed., Springer Verlag Berlin, Vol. 57, pp. 427–449 (1981).Google Scholar
  10. 10.
    D. Ben-Ezra, Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants, Am. J. Ophthalmol., 86:455–461 (1978).Google Scholar
  11. 11.
    R. Langer and J. Folkman, Polymers for the sustained release of proteins and other macromolecules, Nature, 263:797–800 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    M. Ziche and P. M. Gullino, Angiogenesis and neoplastic progression in vitro, J. Natl. Cancer Inst., 69:483–487 (1982).PubMedGoogle Scholar
  13. 13.
    G. K. Brand, Foreign body induced sarcomas, in: “Cancer: a comprehensive treatise,” F. F. Becker ed., Plenium Publ. Corp., New York, Vol. 1, pp. 485–511 (1975).CrossRefGoogle Scholar
  14. 14.
    G. K. Brand, L. C. Buoen and I. Brand, Carcinogenesis from polymer implants. New aspects from chromosomal and transplantation studies during premalignancy, J. Natl. Cancer Inst., 39:663–679 (1967).PubMedGoogle Scholar
  15. 15.
    M. Ziche and P. M. Gullino, Angiogenesis and prediction of sarcoma formation by plastic, Cancer Res., 41:5060–5063 (1981).PubMedGoogle Scholar
  16. 16.
    W. E. Heston and G. Vlahakis, Mammary tumors, plaques and hyper-plastic alveolar nodules in various combinations of mouse inbred strains and the different lines of mammary tumor virus, Int. J. Cancer 36:2505–2610 (1976).Google Scholar
  17. 17.
    D. Medina, Preneoplastic lesions in mouse mammary tumorigenesis, in: “Methods of Cancer Research”, H. Busch, ed., Academic Press, New York, Vol. 7, pp. 3–53 (1973).Google Scholar
  18. 18.
    M. Gimbrone and P. M. Gullino, Angiogenic capacity of preneoplastic lesions of murine mammary gland as a marker of neoplastic transformation, Cancer Res., 36:2611–2620 (1976).PubMedGoogle Scholar
  19. 19.
    M. Gimbrone and P. M. Cullino, Neovascularization induced by intra-ocular xenografts of normal, preneoplastic and neoplastic mouse mammary tissue, J. Natl. Cancer Inst. 56:305–318 (1976).PubMedGoogle Scholar
  20. 20.
    S. S. Brem, H. M. Jensen and P. M. Gullino, Angiogenesis as a marker of preneoplastic lesions of the human breast, Cancer, 41:239–244 (1978).PubMedCrossRefGoogle Scholar
  21. 21.
    G. W. Chodak, C. J. Scheiner and B. R. Zetter, Urine from patients with transitional cell carcinoma stimulated migration of capillary endothelial cells, New Engl. J. Med., 305:869–874 (1981).PubMedCrossRefGoogle Scholar
  22. 22.
    D. Tapper, R. Langer, A. R. Bellow and J. Folkman, Angiogenic capacity as a diagnostic marker for human eye tumors, Surgery, 86:36–40 (1979).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Pietro M. Gullino
    • 1
  1. 1.Dept. Biomedical SciencesUniversity of TorinoItaly

Personalised recommendations